Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

BACKGROUND: We evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 would be associated with worse pathologic finding...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Kowalchuk, Roman O., Lester, Scott C., Graham, Rondell P., Harmsen, William S., Zhang, Lizhi, Halfdanarson, Thorvardur R., Smoot, Rory L., Gits, Hunter C., Ma, Wen Wee, Owen, Dawn, Mahipal, Amit, Miller, Robert C., Wittich, Michelle A. Neben, Cleary, Sean P., McWilliams, Robert R., Haddock, Michael G., Hallemeier, Christopher L., Truty, Mark J., Merrell, Kenneth W.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8147692/
https://ncbi.nlm.nih.gov/pubmed/34046346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.651119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados